Inhibitex, Inc. (NASDAQ:INHX) went up by 5.71% and closed at $5 whereas overall traded volume stood at 3.63 million shares for the day. The current market price is 90.03% more than its last 50 days simple moving average. The RSI value of 85.58 times depicts that the current share value is in highly overbought level. [...]
Novogen Limited (ADR) (NASDAQ:NVGN) surged by 104.72% and closed at $2.17 whereas overall traded volume stood at 5.40 million shares for the day. The current market price is 147.89% more than its last 50 days simple moving average. The RSI value of 86.39 times depicts that the current market price is in highly overbought level. [...]
Illumina, Inc. (NASDAQ:ILMN) is a developer, manufacturer, and marketer of integrated systems for the analysis of genetic variation and biological function. The Company provides a line of products and services that serve the sequencing, genotyping, and gene expression markets. It dropped by 5.21% and closed at $67.12 whereas overall traded volume stood at 2.14 million [...]
Repros Therapeutics Inc. (NASDAQ:RPRX) is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs. Its product pipeline consists of Androxal and Proellex. It jumped up by 30.23% and closed at $3.36 whereas overall traded volume stood at 2.71 million shares for the day as compare to its [...]
Repros Therapeutics Inc. (NASDAQ:RPRX) jumped up by 30.23% and closed at $3.36 whereas overall traded volume stood at 2.71 million shares for the day as compare to its average volume stood at 939.09k shares. The current market price is 52.81% more than its last 50 days simple moving average. Orexigen Therapeutics, Inc. (NASDAQ:OREX) surged by [...]
Aastrom Biosciences, Inc. (NASDAQ: ASTM) is in the development-stage. Aastrom is a regenerative medicine company focused on the development of cell therapies to repair or regenerate damaged or diseased tissues. It witnessed the correction of 22.80% to close at $2.37 with overall traded volume of 10.04 million shares in the last trading day. Its total [...]
Amarin Corporation plc (ADR) (NASDAQ: AMRN) is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. It went up by 7.40% to close at $5.95 with overall traded volume of 5.38 million shares in the last trading session. The share price is likely to move by 1.14 times against 1 point change [...]
MELA Sciences, Inc. (NASDAQ: MELA) is a medical device company focused on the design, development and commercialization of a non-invasive, point-of-care (in the doctor’s office) instrument to assist in the early diagnosis of melanoma. It went up by 4.62% to close at $3.40 whereas overall traded volume stood at 1.53 million shares for the day. [...]
Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) jumped up by 2.03% and closed at $4.03 whereas overall traded volume stood at 5.61 million shares for the day. The share price is likely to move by 1.16 times against 1 point change in market index. Its price to earnings ratio arrives at 5.04 times till its last trading [...]
Cell Therapeutics, Inc. (NASDAQ: CTIC) jumped up by 0.27% and closed at $0.37 whereas overall traded volume stood at 2.97 million shares for the day. The share price is highly reactive to market index as its beta value arrives at 6.07 times till its last trading session. Human Genome Sciences (NASDAQ: HGSI) moved up by [...]